Comparison of short-term clinical outcomes between low-dose prasugrel and clopidogrel as part of triple antithrombotic therapy in patients requiring oral anticoagulant therapy and percutaneous coronary intervention
ConclusionsCombination of low-dose prasugrel and DOAC was associated with lower incidence of MI, ischemic stroke, and blood transfusion. Low-dose prasugrel may be feasible as part of triple therapy in patients undergoing PCI.
Source: PLoS One - Category: Biomedical Science Authors: Hideki Kitahara Source Type: research
More News: Angioplasty | Aspirin | Biomedical Science | Bleeding | Blood Transusion | Cardiology | Clopidogrel | Coronary Angioplasty | Databases & Libraries | Gastroenterology | Heart | Heart Attack | Heart Disease | Ischemic Stroke | Japan Health | Percutaneous Coronary Intervention | Plavix | Stroke | Study | Vitamin K | Vitamins